Physician profile
Christopher M Pace
NPI 1912993080
$4,059.25
in general payments reported to CMS, 2019-2025
38 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $263 · 2021: $341 · 2022: $476 · 2023: $710 · 2024: $777 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,450 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.42 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.77 | 2019-2025 | |
| Boston Scientific Corporation | $401.93 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Pfizer INC. | $309.70 | 2019-2024 | |
| Janssen Biotech, INC. | $294.64 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $292.66 | 2019-2023 | Veozah |
| Coloplast Corp | $186.25 | 2021-2024 | |
| Endo USA, INC. | $177.96 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $174.48 | 2022-2025 | Jelmyto |
| Axonics, INC. | $165.43 | 2022-2024 | Bulkamid |
| Blue Earth Diagnostics | $158.16 | 2021-2025 | Posluma |
| Sumitomo Pharma America, INC. | $153.96 | 2023-2025 | Gemtesa |
| Accord Healthcare, INC. | $139.14 | 2022-2025 | |
| Olympus America INC. | $121.16 | 2021-2025 | Itind System |
| Merck Sharp & Dohme LLC | $105.50 | 2022-2025 | Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $99.07 | 2020-2023 | Aveed, Xiaflex |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.